Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience

European Journal of Neurology

Volumn 6, Issue SUPPL. 4, 1999, Pages s117-s120

  Naver, Hans ^a   Swartling, Carl ^a   Aquilonius, Sten Magnus ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Axillae; Botulinum toxin type A; Excessive sweating; Hyperhidrosis; Palms

Indexed keywords

BOTULINUM TOXIN A; STARCH;

AXILLARY LYMPH NODE; CONFERENCE PAPER; DRUG EFFICACY; DRUG TOLERABILITY; DRY SKIN; EVAPORATION; GRIP STRENGTH; HAND DISEASE; HAND PALM; HUMAN; HYPERHIDROSIS; INJECTION SITE; LABORATORY TEST; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; PATIENT REFERRAL; PRIORITY JOURNAL; REGIONAL ANESTHESIA; SWEATING; TREATMENT OUTCOME;

EID: 0033386848     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1999.tb00028.x     Document Type: Conference Paper

References (3)

1. Finlay AY, Khan GK (1994). Dermatology life quality index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-216.
2. Naumann M, Hamm H, Kinkelin I, Reiners K (1999). Botulinum toxin type A in the treatment of focal axillary and palmar hyperhidrosis and other hyperhidrotic conditions. Eur J Neurol 6 (suppl 4):S111-S115.
3. Naver H, Aquilonius S-M (1997). The treatment of focal hyperhidrosis with botulinum toxin. Eur J Neurol 4 (suppl 2):S75-S79.